Nylim CND US MD CP Eq ETF-UiIQSMETF

13F holders, Q3 2025 (September 30)
7holders +4
4new positions
0sold out
$33.91avg. 13F price*

At the end of Q3 2025, 7 institutions reported holding Nylim CND US MD CP Eq ETF-Ui (IQSM) in their 13F filings, up 4 from Q2 2025. 4 opened new positions and 0 sold out. The largest holders were New York Life Investment Management LLC ($209.0M), Seeds Investor LLC ($3.9M) and Cetera Investment Advisers ($2.8M).

Company
Nylim CND US MD CP Eq ETF-Ui
Filed as
NEW YORK LIFE INVESTMENTS ET (Q3 2025)
CUSIP
45409B248
Latest filing quarter
Q2 2026

History

Number of 13F holders

02468 Q1 2024: 3Q1 2024Q2 2024: 2Q2 2024Q3 2024: 3Q3 2024Q4 2024: 3Q4 2024Q1 2025: 3Q1 2025Q2 2025: 3Q2 2025Q3 2025: 7Q3 2025Q4 2025: 6Q4 2025Q1 2026: 6Q1 2026Q2 2026: 7Q2 2026

Total Exit/New Position Q2 2025 → Q3 2025

InstitutionsTotal Value
New Positions4$3.2M
Exits0$0

All 13F filers, Q2 2025 → Q3 2025: 133,693 shares bought and 213,377 shares sold, net −79,684 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 7 holders

New York Life Investment Management LLC 1.84% Reduce -3.3% 6,163,223 $209.0M
Seeds Investor LLC 0.83% Add +50.5% 115,933 $3.9M
Cetera Investment Advisers 0.00% New 81,265 $2.8M
Susquehanna International Group, LLP 0.00% New 10,233 $347K
Rossby Financial, LCC 0.04% New 3,259 $111K
Morgan Stanley 0.00% New 13 $441
UBS Group AG 0.00% Reduce -95.5% 13 $441

"% of holder's portfolio" is IQSM's weight in each manager's 13F, not the share of Nylim CND US MD CP Eq ETF-Ui the manager owns.